PLCB2 and breast neoplasm: On the contrary, CD133high cells express PLC-β2 at levels significantly lower than CD133low cells, in accordance with our previous data indicating that, in breast tumor-derived cells, PLC-β2 amount positively correlates with proliferation rate and motility [16].